254 related articles for article (PubMed ID: 37110771)
1. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application.
Tao N; Xu X; Ying Y; Hu S; Sun Q; Lv G; Gao J
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110771
[TBL] [Abstract][Full Text] [Related]
2. Thymalfasin for the treatment of chronic hepatitis B.
Chien RN; Liaw YF
Expert Rev Anti Infect Ther; 2004 Feb; 2(1):9-16. PubMed ID: 15482167
[TBL] [Abstract][Full Text] [Related]
3. Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era.
Mao L
Int Immunopharmacol; 2023 Apr; 117():109952. PubMed ID: 36871535
[TBL] [Abstract][Full Text] [Related]
4. Thymosin α1 activates complement receptor-mediated phagocytosis in human monocyte-derived macrophages.
Serafino A; Pica F; Andreola F; Gaziano R; Moroni N; Moroni G; Zonfrillo M; Pierimarchi P; Sinibaldi-Vallebona P; Garaci E
J Innate Immun; 2014; 6(1):72-88. PubMed ID: 23797159
[TBL] [Abstract][Full Text] [Related]
5. Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing.
Bai H; Liang L; Qi X; Xu Y; Liu Y; Ren D; Cai Z; Mao W; Wang X; Qin H; Hu F; Shi B
Int Immunopharmacol; 2023 Nov; 124(Pt B):110983. PubMed ID: 37769533
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells.
Wang S; Huang M; Chen M; Sun Z; Jiao Y; Ye G; Pan J; Ye W; Zhao J; Zhang D
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37295817
[TBL] [Abstract][Full Text] [Related]
7. Dual effect of Thymosin α 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonists.
Giacomini E; Severa M; Cruciani M; Etna MP; Rizzo F; Pardini M; Scagnolari C; Garaci E; Coccia EM
Expert Opin Biol Ther; 2015; 15 Suppl 1():S59-70. PubMed ID: 26096650
[TBL] [Abstract][Full Text] [Related]
8. Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
Romani L; Bistoni F; Montagnoli C; Gaziano R; Bozza S; Bonifazi P; Zelante T; Moretti S; Rasi G; Garaci E; Puccetti P
Ann N Y Acad Sci; 2007 Sep; 1112():326-38. PubMed ID: 17495242
[TBL] [Abstract][Full Text] [Related]
9. Expression of thymosin alpha1 concatemer in transgenic tomato (Solanum lycopersicum) fruits.
Chen Y; Wang A; Zhao L; Shen G; Cui L; Tang K
Biotechnol Appl Biochem; 2009 Apr; 52(Pt 4):303-12. PubMed ID: 18752465
[TBL] [Abstract][Full Text] [Related]
10. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
[TBL] [Abstract][Full Text] [Related]
11. Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK.
Mandaliti W; Nepravishta R; Pica F; Vallebona PS; Garaci E; Paci M
Molecules; 2017 Oct; 22(11):. PubMed ID: 29077041
[TBL] [Abstract][Full Text] [Related]
12. Gene cloning, expression and immune adjuvant properties of the recombinant fusion peptide Tα1-BLP on avian influenza inactivate virus vaccine.
Zhang C; Zhou J; Cai K; Zhang W; Liao C; Wang C
Microb Pathog; 2018 Jul; 120():147-154. PubMed ID: 29730515
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients.
Arase Y; Tsubota A; Suzuki Y; Suzuki F; Kobayashi M; Someya T; Akuta N; Hosaka T; Saitoh S; Ikeda K; Kobayashi M; Kumada H
Intern Med; 2003 Oct; 42(10):941-6. PubMed ID: 14606705
[TBL] [Abstract][Full Text] [Related]
14. Restoration of immunocyte functions by thymosin alpha1 in cyclophosphamide-induced immunodeficient mice.
Ohmori H; Kamo M; Yamakoshi K; Nitta MH; Hikida M; Kanayama N
Immunopharmacol Immunotoxicol; 2001 Feb; 23(1):75-82. PubMed ID: 11322651
[TBL] [Abstract][Full Text] [Related]
15. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.
Mutchnick MG; Lindsay KL; Schiff ER; Cummings GD; Appelman HD; Peleman RR; Silva M; Roach KC; Simmons F; Milstein S; Gordon SC; Ehrinpreis MN
J Viral Hepat; 1999 Sep; 6(5):397-403. PubMed ID: 10607256
[TBL] [Abstract][Full Text] [Related]
16. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
[TBL] [Abstract][Full Text] [Related]
17. Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
Li W; Song L; Wu S; Xue X; Zhang L; He L; Han W; Wang Q; Ling R; Zhang W; Yan Z; Zhang Y
Int J Biol Sci; 2011; 7(5):618-28. PubMed ID: 21647330
[TBL] [Abstract][Full Text] [Related]
18. Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.
Ricci D; Etna MP; Severa M; Fiore S; Rizzo F; Iannetta M; Andreoni M; Balducci S; Stefanelli P; Palamara AT; Coccia EM
Int Immunopharmacol; 2023 Apr; 117():109996. PubMed ID: 36933449
[TBL] [Abstract][Full Text] [Related]
19. Construction, expression and characterization of human interferon alpha2b-(G4S)n-thymosin alpha1 fusion proteins in Pichia pastoris.
Yang YF; Yuan HY; Liu NS; Chen XL; Gao BY; Lu H; Li YY
World J Gastroenterol; 2005 May; 11(17):2597-602. PubMed ID: 15849818
[TBL] [Abstract][Full Text] [Related]
20. Signaling pathways leading to the activation of IKK and MAPK by thymosin alpha1.
Peng X; Zhang P; Wang X; Chan J; Zhu M; Jiang M; Tuthill C; Wan Y; Dragoi AM; Chu WM
Ann N Y Acad Sci; 2007 Sep; 1112():339-50. PubMed ID: 17567943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
